|
Mutation Information
|
Mutation Site
|
M184V |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Relevant Drug
|
entecavir (ETV);lamivudine (LAM) |
|
Country
|
Australia and the United State |
Literature Information
|
PubMed PMID
|
18453854
|
|
Disease
|
HBV-HIV coinfection
|
|
Published Year
|
2008 |
|
Journal
|
AIDS (London, England) |
|
Title
|
The anti-HIV activity of entecavir: a multicentre evaluation of lamivudine-experienced and lamivudine-naive patients. |
|
Author
|
Sasadeusz J,Audsley J,Mijch A,Baden R,Caro J,Hunter H,Matthews G,McMahon MA,Olender SA,Siliciano RF,Lewin SR,Thio CL |
|
Evidence
|
The M184V mutation emerged in six patients receiving entecavir, including three antiretroviral therapy-naive patients.
|
|
|
HBV Mutation Detail Information